Study of Predictive Factors of Chemoresistance in Ovarian Cancer (FaCliBioCCo)

Rennes University Hospital

Status: Completed

Conditions: Ovarian Cancer

Treatments: Procedure: Cancer treatment

Study type: Observational

Funder types: Other

Identifiers

NCT02878122

35RC15_3007_FaCliBioCCo

Details and patient eligibility

About

Epithelial ovarian cancer (EOC) has a poor prognosis. EOC management requires debulking surgery and chemotherapy based on taxol and carboplatine. Initial response is often good, but most often a recurrence occurred in the first 18 months. Early recurrence signs chemoresistance and palliative treatment. The study of predictive clinical or biological factors is required to adapt therapeutic and develop new treatments.

Enrollment: 13 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patient > 18 years of age
• patient with histological proven epithelial ovarian cancer

Exclusion criteria

• patients who can not give their own consent
• patients without ovarian cancer

Trial design

13 participants in 1 patient group

Patients with epithelial ovarian cancer

Description:

Cancer treatment

Treatment:

Procedure: Cancer treatment